Characterization by flow cytometry and fluorescein-methotrexate labeling of hydrophilic and lipophilic antifolate resistance in cultured mammalian cells
- PMID: 8292810
- DOI: 10.1097/00001813-199310000-00002
Characterization by flow cytometry and fluorescein-methotrexate labeling of hydrophilic and lipophilic antifolate resistance in cultured mammalian cells
Abstract
The aim of this review is to summarize currently available information on the rapid screening and initial characterization of the different mechanisms of resistance to hydrophilic [e.g. methotrexate (MTX)] and lipophilic antifolates [e.g. trimetrexate (TMTX)] in cultured mammalian cells using fluorescein-methotrexate (F-MTX) and flow cytometry. Toward this end an integrative F-MTX labeling and flow cytometry-based protocol is proposed here to facilitate the rapid identification of modes of antifolate resistance in a heterogenous drug-resistant cell population or in clonal derivatives. Following antifolate selection, drug-resistant cells are first labeled with F-MTX in order to saturate intracellular dihydrofolate reductase (DHFR). F-MTX-labeled cells are then subjected to flow cytometric analysis and mean fluorescence/cell is determined. Thus, increased F-MTX staining is an indication of overproduction of the target enzyme for antifolates, DHFR, as a result of DHFR gene amplification. In contrast, significantly reduced cellular F-MTX labeling could be an indication of the existence of a structurally altered DHFR displaying a decreased affinity for antifolates. Alternatively, antifolate-resistant cells frequently display wild-type F-MTX labeling; these cells are subjected to competition with hydrophilic and lipophilic antifolates in order to examine whether the process of antifolate accumulation is deficient. Cells that lose F-MTX labeling upon competition with lipophilic antifolates yet still retain it with hydrophilic antifolates, are likely to possess transport alteration(s) that impair or abolish the accumulation of hydrophilic but not of lipophilic antifolates. In contrast, cells that lose their F-MTX labeling after competition with hydrophilic antifolates but retain it with lipophilic antifolates, possess a deficient accumulation of lipophilic antifolates.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Characterization of a lipophilic antifolate resistance provoked by treatment of mammalian cells with the antiparasitic agent pyrimethamine.J Biol Chem. 1993 Feb 25;268(6):4556-66. J Biol Chem. 1993. PMID: 8440739
-
Characterization of the coexisting multiple mechanisms of methotrexate resistance in mouse 3T6 R50 fibroblasts.J Biol Chem. 1992 Mar 25;267(9):5776-84. J Biol Chem. 1992. PMID: 1372892
-
Flow cytometric characterization of antifolate resistance in cultured mammalian cells using fluoresceinated methotrexate and daunorubicin.Cancer Res. 1990 Aug 15;50(16):4946-50. Cancer Res. 1990. PMID: 2143099
-
The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.Drug Resist Updat. 2006 Aug-Oct;9(4-5):227-46. doi: 10.1016/j.drup.2006.09.001. Epub 2006 Nov 7. Drug Resist Updat. 2006. PMID: 17092765 Review.
-
Molecular mechanisms of resistance to antifolates, a review.Acta Biochim Pol. 1995;42(4):457-64. Acta Biochim Pol. 1995. PMID: 8852336 Review.
Cited by
-
Flow cytometry and cell sorting of heterogeneous microbial populations: the importance of single-cell analyses.Microbiol Rev. 1996 Dec;60(4):641-96. doi: 10.1128/mr.60.4.641-696.1996. Microbiol Rev. 1996. PMID: 8987359 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources